Newsletter Archive
-
03.11.24 -- Making Inroads In Alzheimer's
3/11/2024
03/11/24 Life Science Leader Newsletter
-
03.08.24 -- Collaborating With NORD
3/8/2024
03/08/24 Life Science Leader Newsletter
-
03.08.24 -- New Episodes: Yescarta's Reduced Median Turnaround Time, Inhalable mRNA and more!
3/8/2024
03/08/24 Life Science Leader Newsletter
-
03.06.24 -- Big Pharma Big On ADCs
3/6/2024
03/06/24 Life Science Leader Newsletter
-
03.04.24 -- Companies To Watch: Antiva Biosciences
3/4/2024
03/04/24 Life Science Leader Newsletter
-
03.04.24 -- A Patient- And Planet-Centric Approach To Enhancing Medicines In Development
3/4/2024
03/04/24 Life Science Leader Newsletter
-
03.01.24 -- State Of The Orphan Space
3/1/2024
03/01/24 Life Science Leader Newsletter
-
02.29.24 -- Enhancing Drug Development Outcomes Through Early Assessment Strategies
2/29/2024
02/29/24 Life Science Leader Newsletter
-
02.28.24 -- Pros And Cons Of Copromotion
2/28/2024
02/28/24 Life Science Leader Newsletter
-
02.26.24 -- Ruthless Resourcing Rules For CEOs
2/26/2024
02/26/24 Life Science Leader Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more